Hesperidin a citrus bioflavonoid modulates hepatic biotransformation enzymes and enhances intrinsic antioxidants in experimental breast cancer rats challenged with 7, 12- Dimethylbenz (a) anthracene

Journal of Experimental Therapeutics and Oncology

Volumn 9, Issue 4, 2012, Pages 321-335

  Nandakumar, Natarajan ^a   Balasubramanian, Maruthaiveeran Periyasamy ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Antioxidants; Biotransformation enzymes; Breast cancer; DMBA; Genotoxin; Hesperidin; Oxidative stress

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; BIOFLAVONOID; DRUG METABOLIZING ENZYME; HESPERIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CITRUS; CONTROLLED STUDY; DRUG TRANSFORMATION; FEMALE; GENOTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TREATMENT DURATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARCINOGENS; CYTOCHROME P-450 ENZYME SYSTEM; CYTOCHROMES B5; FEMALE; GLUTATHIONE; HESPERIDIN; MAMMARY NEOPLASMS, EXPERIMENTAL; NADPH-FERRIHEMOPROTEIN REDUCTASE; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 84860646179     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (107)

1. Hall M, Grover PL. Polycyclic aromatic hydrocarbons metabolism, activation and tumor initiation. In: Cooper C.S, Grover P.L. (Eds.), Handbook of Experimental Pharmacoloy. Springer-Verlag, New York, pp. 327-372, 1990.
2. Christou M, Savas U, Schroeder S, Shen X, Thompson T, Gould MN, Jefcoate C.R. Cytochromes CYP1a1 and CYP1B1 in the rat mammary gland: cell specific expression and regulation by polycyclic aromatic hydrocarbons and hormones. Mol Cell Endocrinol 115: 41-50, 1995.
3. Cavalcanti C, Costa-Lotufo LV, Moraes MO, Burbano RR, Silveria ER, Cunha KM, Rao VS, Moura DJ, Rosa RM, Henruques JA, Pessoa C. Genotoxicity evaluation of kaurenoic acid, a bioactive diterpenoid present in Copaiba oil. Food Chem Toxicol 44(3): 338-392, 2006.
4. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: A Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
5. Singletary KW, Jackson SJ, Milner J. A non-nutritive compound in foods as modifiers of the cancer process. In Bendich A, Deckelbaum R.J (Eds.), Preventive Nutrition: The comprehensive guide for health professionals. Humana Press, Totowa, NY. pp. 55-58, 2005.
6. Brown NS, Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: Its effects on the growth, metastasic potential and response to therapy of breast cancer. Breast Cancer Res 3: 323-327, 2001. (Pubitemid 32851163)
7. Mittal A, Pathania V, Agarwal PK, Prasad J, Singh S, Goel HC. Influence of Podophyllum hexandrum on endogenous antioxidant defense system in mice: possible role in radio protection. J Ethanopharmacol 76: 53-262, 2001.
8. Prakash J, Gupta SK. Chemopreventive activity of Ocimum Sanctum seed oil. J Ethanopharmacol 72: 29-34, 2000.
9. Sabu MC, Kuttan R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethanopharmacol 81: 155-160, 2002. (Pubitemid 34628497)
10. Vijayavel K, Anbuselvam C, Balasubramanian MP. Free radical scavenging activity of the marine mangrove Rhizophora apiculata bark extract with reference to naphthalene induced mitochondrial dysfunction. Chem Biol Interact 163: 170-175, 2006. (Pubitemid 44572219)
11. Susana BE, Evelina GF, Luciana N, Josefina R, Victoria S, Patricia AMW. Antioxidant effects of the VO(IV) hesperidin complex and its role in cancer chemoprevention. J Biol Inorg Chem 13: 435-447, 2008.
12. Emim JADS, Oliveira AB, Japa AJ. Pharmcological evaluation of anti-inflammatory activity of citrus bioflavonoid, hesperidin and the isoflavonoids duratin and claussequinone, in rats and mice. J Pharm Pharmacol 46: 118-122, 1994.
13. Son HS, Kim HS, Ju JS. Effects of rutin and hesperidin on total cholesterol concentration, transaminase and alkaline phosphatase activity in carbon tetra chloride treated rats. Hanguk Nonghwa Hakhoe Chi 34: 318-326, 1991.
14. Galati EM, Monforte MT, Kirjavainen S, Foretieri AM, Tripodo MM. Biological effects of hesperidin- a citrus flavonoid. Part 1. Anti-inflammatory and analgesic activity. Farmaco 49: 709-712, 1994. (Pubitemid 24356920)
15. Yang M, Tanaka T, Hirose Y, Deguchi T, Mori H, Kawada Y. Chemopreventive effects of diosmin and hesperidin on N-butyl- N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice. Int J Cancer 73: 719-724, 1997. (Pubitemid 127483070)
16. Montanari A, Chen J, Widmer W. Citrus flavonoids: a review of past biological activity against disease. Discovery of new flavonoids from Dancy tangerine cold pressed peel oil solids and leaves. Adv Exp Med Biol 439: 103-116, 1998.
17. Winawer W, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterol 124: 544-560, 2003. (Pubitemid 36169269)
18. Garg A, Garg S, Zaneveld LJD, Single AK. Chemistry and pharmacology of the Citrus flavonoids hesperidin. Phytother Res 15: 655-669, 2001. (Pubitemid 34016792)
19. Barros AC, Muranaka EN, Mori LJ, Pelizon CH, Iriya K, Giocondo G, Pinotti JA. Induction of experimental mammary carcinogenesis in rats with 7,12-dimethylbenz (a) anthracene. Rev Hosp Clin Fac Med Sao Paulo 59(5): 257-261, 2004.
20. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469-474, 1974.
21. Sinha AK. Colorimetric assay of catalase. Anal Biochem 47: 389-394, 1972.
22. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: Biochemical role as a component of glutathione peroxidase. Science 179: 588-590, 1973.
23. Moron MS, Depierre JW, Mannervik B. Levels of glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta 582: 67-78, 1979. (Pubitemid 9065588)
24. Omaye ST, Turnbull JD, Sauberlich HE. Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 62: 3-11, 1971.
25. Desai ID. Vitamin E analysis methods for animal tissues. Methods Enzymol 105: 138-144, 1984.
26. Boyd MR, Burka LT. In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol. J Pharmacol Exp Ther 207: 687-697, 1978. (Pubitemid 9115125)
27. Kamath SA, Narayanan KA. Interaction of Ca2+ with endoplasmic reticulum of rat liver. A standardized procedure for the isolation of rat liver microsomes. Anal Biochem 48: 53-61, 1972.
28. Omura T, Sato R. The carbon monoxide binding pigment of liver microsomes. J Biol Chem 239: 2370-2378, 1964.
29. Philips AH, Langdon RG. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization and kinetic studies. J Biol Chem 237: 2652-2660, 1962.
30. Habig WH, Pabste MJ, Jakboy WB. Glutathione-S-transferase: the first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139, 1974.
31. th Edn. New York, McGrawHill, pp. 579-80, 1998.
32. Hollman S, Touster O. Alterations in tissue levels of Urdine diphosphate-glucose dehydrogenase, Uridine diphosphateglucuronic acid pyrophosphatase and glucuronyl transferase induced by substances influencing the production of ascorbic acid. Biochem Biophys Acta 62: 338-352, 1962.
33. Rice-Evens CA, Diplock AT. Current status of antioxidant therapy. Free Rad Biol Med 150: 77-96, 1993.
34. Lai H, Singh NP. Oral artemisinin prevents and delays the development of 7, 12-dimethylbenz (a) anthracene (DMBA)-induced breast cancer in the rat. Cancer Lett 231: 43-48, 2006. (Pubitemid 41779452)
35. Johnson F, Giulivi C. Superoxide dismutases and their impact upon human health. Mol Aspects Med 26(4-5): 340-52, 2005. (Pubitemid 41225357)
36. Weydert CJ, Waugh TA, Ritchie JM, Iyer KS, Smith JL, Li L, Spitz DR, Oberley LW. Over expression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Rad Biol Med 41: 226-237, 2006. (Pubitemid 43928496)
37. Gupta M, Mazumder UK, Kumar RSV, Sivakumar T, Vamsi MLM. Antitumour activity and antioxidant status of Caesalpina Bonducella against Ehrlich ascites carcinoma in Swiss albino mice. J Pharmacol Sci 94:177-184, 2004. (Pubitemid 38405132)
38. Moselhy SS, Mohamed A, Al mslmani B. Chemopreventive effect of lycopene alone or with melatonin against the genesis of oxidative stress and mammary tumors induced by 7,12- dimethylbenz (a) anthracene in Sprague dawely female rats. Mol Cell Biochem 319: 175-180, 2008.
39. Cotelle N, Bernier JL, Catteau JP, Pommery J, Wallet JC, Gaydou EM. Antioxidant properties of hydroxyl flavones. Free Rad Biol Med 20(1): 35-43, 1996.
40. Chelikani P, Fita I, Loewen P. Diversity of structures and properties among catalases. Cell Mol Life Sci 61(2): 192-208, 2004. (Pubitemid 38183572)
41. Hiner AN, Hernández-Ruiz J, Rodríguez-López JN, García-Cánovas F, Brisset NC, Smith AT, Arnao MB, Acosta M. Reactions of the class II peroxidases, lignin peroxidase and Arthromyces ramosus peroxidase, with hydrogen peroxide. Catalase-like activity, compound III formation, and enzyme inactivation. J Biol Chem 277(30): 26879-85, 2002. (Pubitemid 34951696)
42. Cameron E, Pauling L, Leibobiz B. Ascorbic acid and cancer (Review). Cancer Res 39: 633-681, 1979.
43. Talas ZS, Yilmaz I, Ozdemir I, Ates B, Gok Y, Cetinkaya B. Role of synthesized organoselenium compounds on protection of rat erythrocytes from DMBA-induced oxidative stress. Biol Trace Elem Res 128: 167-175, 2009.
44. Gromadzinska J, Reszka E, Bruzelius K, Wasowicz W, Akesson B. Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements. Eur J Nutr 47(2): 29-50, 2008. (Pubitemid 351644179)
45. Bewick M, Coutie W, Tudhope GR. Superoxide dismutase, glutathione peroxidase and catalase in the red cells of patients with malignant lymphoma. Br J Haematol 65: 347-350, 1987. (Pubitemid 17044680)
46. Nagao M, Wakabayashi K, Suwa Y, Kobayashi T. Alteration of mutagenic potentials by peroxidase, catalase and superoxide dismutase. In: Antimutagenesis and anticarcinogenesis mechanism. (Eds.) Hartman APE, Kada T, Hollaender A. Plenum Press, New York, pp. 73-80, 1986.
47. Bhuvaneswari V, Velmurugan B, Balasenthil S, Ramachandran CR, Nagini S. Chemopreventive efficacy of lycopene on 7,12- dimethyl benz (a) anthracene induced hamster buccal pouch carcinogenesis. Fitoterapia 72: 865-874, 2001. (Pubitemid 33122194)
48. Kaufmann Y, Luo S, Johnson A, Babb K, Klimberg S. Timing of oral glutamine on DMBA-induced tumorigenesis. J Surg Res 111: 158-165, 2003. (Pubitemid 36814055)
49. Duh PD, Wu SC, Chang LW, Chu HL, Yen WJ, Wang BS. Effects of three biological thiols on antimutagenic and antioxidant enzyme activities. Food Chem 114: 87-92, 2009.
50. Trickler D, Shklar G, Schwartz J. Inhibition of oral carcinogenesis by glutathione. Nutr Cancer 20(2): 139-144, 1993. (Pubitemid 23270882)
51. Exner R, Wessner B, Manhart N, Roth E. Therapeutic potential of glutathione. Wien Klin Wochenschr 112(14): 610-6, 2000. (Pubitemid 30621366)
52. Amores-Sanchez MI, Medina MA. Glutamine, as a precursor of glutathione, and oxidative stress. Mol Genet Metab 67(2): 100-5, 1999. (Pubitemid 29393236)
53. Johnson AT, Kaufmann Y, Luo S, Babb K, Hawk R, Klimberg VS. Gut glutathione metabolism and changes with 7, 12-DMBA and glutamine. J Surg Res 115: 242-246, 2003. (Pubitemid 38021914)
54. Comporti M. Three models of free-radicals induced cell injury. Chem Biol Interact 72: 1-56, 1989. (Pubitemid 19284045)
55. Tsao CS. An overview of ascorbic acid chemistry and biochemistry, In vitamin C, in health and disease, L. Packer, J. Fuchs (Eds.), Marcel Dekker Inc., New York, pp. 25-58, 1997.
56. Akhilender Naidu K. Vitamin C in human health and disease is still a mystery? An overview. Nutr J 2: 1-10, 2003.
57. Anbuselvam C, Vijayavel K, Balasubramanian MP. Protective effect of Operculina turpethum against 7,12-dimethylbenz(a) anthracene induced oxidative stress with reference to breast cancer in experimental rats. Chem Biol Interact 168: 229-236, 2007. (Pubitemid 46976883)
58. Vijayavel K, Anbuselvam C, Balasubramanian MP. Napthalene induced hematological disturbances and oxidative stress in an estuarine edible crab Scylla serrata. Environ Toxicol 20: 464- 466, 2005.
59. Veena K, Shanthi P, Sachdanandam P. Therapeutic efficacy of Kalpaamruthaa on reactive oxygen/nitrogen species levels and antioxidative system in mammary carcinoma bearing rats. Mol Cell Biochem 294: 127-135, 2007. (Pubitemid 46188893)
60. Kline K, Lawson KA, Yu W. Vitamin E and breast cancer prevention: current status and future potential. J Mammary Gland Biol Neoplasia 8: 91-102, 2003. (Pubitemid 38129952)
61. Schindler R, Mentlein R. Flavonoids and vitamin-E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumour cells. J Nutr 136: 1477-1482, 2006. (Pubitemid 43765348)
62. Eicholzer M, Stalielin HB, Gey KF. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year old follow-up of the prospective basal study. In J Cancer 66: 145-150, 1996. (Pubitemid 26248191)
63. You H, Yu W, Sanders BG. RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation. Cell Growth Differ 12: 471-480, 2001. (Pubitemid 32906092)
64. Kline K, Yu W, Sanders BG. Vitamin E: mechanisms of action as tumor cell growth inhibitiors. J Nutr 131: 161-163, 2001.
65. Goetz ME, Luch A. Reactive species: A cell damaging rout assisting to chemical carcinogenesis. Cancer Lett 266: 73-83, 2008.
66. Dasgupta T, Rao AR, Yadava PK. Modulatory effect of Henna leaf (Lawsonia inermis) on drug metabolizing phase I and phase II enzymes, antioxidant enzymes, lipid peroxidation and chemically induced skin and forestomach papillomagenesis in mice. Mol Cell Biochem 245: 11-22, 2003. (Pubitemid 36416817)
67. Herzfeld A, Greengard O. The effect of lymphoma and other neoplasms on hepatic and plasma enzymes of the host rat. Cancer Res 37: 231-238, 1977. (Pubitemid 8009303)
68. Ip C, Lisk DJ. Modulation of phase I and phase II xenobiotic metabolizing enzymes by selenium-enriched garlic in rats. Nutr Cancer 28: 184-188, 1997. (Pubitemid 27396208)
69. Moore CJ, Tricomi WA, Gould MN. Interspecies comparison of polycyclic aromatic hydrocarbon metabolism in human and rat mammary epithelial cells. Cancer Res 46: 4946-4952, 1986. (Pubitemid 16008244)
70. Maltzman TH, Christou M, Gould MN, Jefcoate CR. Effects of monoterpenoids on in vivo DMBA-DNA adducts formation and on phase I hepatic metabolizing enzymes. Carcinogenesis 12: 2081-2087, 1991.
71. 450 enzymes in endogenous signaling pathways and environmental carcinogenesis. Nat Rev Cancer 6: 947-960, 2006.
72. Mukherjee S, Koner BC, Ray S, Ray A. Environmental contaminants in pathogenesis of breast cancer. Ind J Exp Biol 44: 597-617, 2006. (Pubitemid 44964998)
73. Sing MS, Michael M. Role of Xenobiotic metabolic enzymes in cancer epidemiology. Verma M. (Ed.), Methods of Molecular Biology, Cancer Epidemiology, Vol. 472, Humana Press, Totowa, NJ. pp. 243-264, 2009.
74. Moon YJ, Wang X, Morris ME. Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism. Toxicol Invitro 20: 187-210, 2006. (Pubitemid 43087702)
75. 450 reductase over expression does not enhance the aerobic cytotoxicity of doxorubicin in human breast cancer cell lines. Cancer Res 63: 6914-6919, 2003.
76. Windmill KF, McKinnon RA, Zhu X, Gaedigk A, Grant DM, McManus ME. The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies. Mutat Res 376(1-2): 153-160, 1997. (Pubitemid 27248598)
77. Hecht SS. Biochemistry, biology and carcinogenicities of tobacco specific N-Nitrosamines. Chem Res Toxicol 11(6): 560-603, 1998.
78. Om Ali Y, Khawaga E, Tarwk A, Mohammed S, Elshal F. Protective role of Eygptian propolis against tumor in mice. Clin Chim Acta 338: 11-16, 2003.
79. Mathivadhani P, Shanthi P, Sachdanandam P. Effect of Semecarpus anacardium Linn. nut extract on mammary and hepatic expression of xenobiotic enzymes in DMBA-induced mammary carcinoma. Environ Toxicol Pharmacol 23: 328-334, 2007. (Pubitemid 46274482)
80. Timbrell JA. Principles of Biochemical Toxicology. 2nd Edn., Taylor and Francis. London, 1991.
81. Kloepper-Sams PJ, Stegeman JJ. Effects of temperature acclimation on the expression of hepatic cytochrome P4501A RNA and protein in the fish Fundules heteroclitus. Arch Biochem Biophys 299: 38-46, 1992.
82. Cajelli E, Ferraris A, Brambilla G. Mutagenecity of 4-hydroxynoneal in V79 Chinese hamster cells. Mutat Res 190: 169-171, 1987. (Pubitemid 17024825)
83. Commandeur JNM, Stijntjes CJ, Vermeulen NPE. Enzymes and transport systems involved in the formation and disposition of glutathione-S-conjugates. Role in bioactivation and detoxication mechanism of xenobiotics. Pharmacol Rev 47: 271-33, 1995.
84. George SG. Enzymology and molecular biochemistry of phase II xenobiotic conjugating in fish. In: Malish DC, Osternder GK (eds). Aquatic Toxicology: Molecular Biochemical and cellular perspective, Lewis Publishers, CRC Press, pp. 37-85, 1994.
85. Varanasi U, Stein JE, Nishimento M, Reichert WL, Collier TK. Chemical carcinogenesis in fish: uptake, activation and detoxification of organic xenobiotics. Environ Health Perspect 71: 155-170, 1987. (Pubitemid 17115234)
86. Wattenberg LW. Chemoprevention of cancer by naturally occurring and synthetic compounds. In: Wattenberg LW, Lipkin M, Boone CW, Kellof GJ. (Eds) Cancer chemoprevention. CRC Press, Boca Raton, pp. 19-39, 1985.
87. Sheweita SA, Tilmisany AK. Cancer and Phase II drug metabolizing enzymes. Curr Drug Metabol 4: 45-58, 2003. (Pubitemid 36131683)
88. Fiander H, Schneider H. Dietary orthophenols that induce glutathione S-transferase and increase the resistance of cells to hydrogen peroxide are potential cancer chemo preventives that act by two mechanisms: The alleviation of oxidative stress and the detoxification of mutageneic xenobiotics. Cancer Lett 156: 117-124, 2000. (Pubitemid 30394668)
89. 450 and glutathione transferase expression in human breast cancer. Clin Cancer Res 9(5): 1705-1709, 2003.
90. Michael M, Doherty MM. Tumoral drug metabolism: overview and its implications for cancer therapy. J Clin Oncol 23: 205-229, 2005. (Pubitemid 41702640)
91. Jensson H, Eriksson LC, Mannervik B. Selective expression of glutathione transferase isoenzymes in chemically induced preneoplastic rat hepatocyte nodules. FEBS Lett 187: 115-120, 1995.
92. Sato K, Satoh K, Hatayama I, Tsuchida S, Soma Y, Shiratori Y, Tateoka N, Inba Y, Kitahara A. Placental gluthione-S-transferase as a marker for neoplastic tissues. In: Mantle TJ, Pickett CB, Hayes JD. (eds). Glutathione-S-tranferase and carcinogenesis, New York, Taylor and Francis, pp. 127-137, 1987.
93. Bishayee A, Oinam S, Basu M, Chatterjee M. Vanadium chemoprevention of 7,12-Dimethylbenz (a) anthracene-induced rat mammary carcinogenesis: probable involvement of representative hepatic phase I and II xenobiotic metabolizing enzymes. Breast Cancer Res Treat 63: 133-145, 2000.
94. Kleiner HE, Xia X, Sonoda J, Zhang J, Pontius E, Abey J, Evans RM, Moore DD, Digiovanni J. Effects of naturally occurring coumarins on hepatic drug-metabolizing enzymes in mice. Toxicol Appl Pharmacol 232: 337-350, 2008.
95. Wang AS, Ramanathan B, Chien YH, Goparaju CM, Jan KY. Comet assay with nuclear extract inhibition. Anal Biochem 337(1): 70-75, 2005. (Pubitemid 40092780)
96. Vrhovac VG, Gajski G, Trosic I, Pavicic I. Evaluation of basal DNA damage and oxidative stress in wistar rat leukocytes after exposure to microwave radiation. Toxicol doi:10.1016/j. tox.2009.02.008, 2009.
97. Padmavathi R, Senthilnathan P, Sakthisekaran D. Therapeutic effect of propolis and paclitaxel on hepatic phases I and II enzymes and marker enzymes in dimethlybenz (a) anthracene induced breast cancer in female rats. Comp Biochem Physiol Toxicol Pharmacol 143: 349-354, 2006. (Pubitemid 43850414)
98. Elegbede JA, Maltzman TH, Elson CE, Gould MN. Effects of anticarcinogenic monoterpenes on phase II hepatic metabolizing enzymes. Carcinogenesis 14: 1221-1223, 1993. (Pubitemid 23193555)
99. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Belanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, Lancet D, Louisot P, Magdalou J, Chowdhury JR, Ritter JK, Schachter H, Tephly TR, Tipton KF, Nebert DW. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7: 255-269, 1997. (Pubitemid 27358064)
100. Mulder GJ, Coughty MWH, Burchell B. Glucuronidation. In: Mulder GJ. Conjugation reactions in drug metabolism; an Integrated Approach. Taylor and Francis, London, pp- 51-105, 1990.
101. Letelier ME, Pimentel A, Pino P, Lepe AM, Faundez M, Aracena P, Speisky H. Microsomal UDP-glucuronyltransferase in rat liver: oxidative activation. Basic Clin Pharmacol Toxicol 96: 480-486, 2005. (Pubitemid 40835704)
102. Li D, Wang M, Firozi PF, Chang P, Znang W, Baer-Dubowsha W, Moorthy B, Vulimiri SV, Goth-Goldstein R, Weyand EH, DiGiovanni J. Characterization of major aromatic DNA adducts detected in human breast tissues. Environ Mol Mutagen 39(2-3): 193-200, 2002. (Pubitemid 34260493)
103. Matsui A, Ikeda T, Enomoto K, Nakashima H, Omae K, Watanable M, Hibi T, Kitajima M. Increased formation of oxidative DNA damage, 8-hydroxy-2- deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett 151(1): 87-95, 2000. (Pubitemid 30155589)
104. Steinkellner H, Rabot S, Freywald C, Nobis E, Scharf G, Chabicovsky M, Knasmuller S, Kassie F. Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens. Mutat Res 480-481: 285-297, 2001. (Pubitemid 32744835)
105. Galati G, O'Brien PJ. Potential toxicity of flavonoids and other dietary phenoics: significance for their chemopreventive and anticancer properties. Free Rad Biol Med 37(3): 287-303, 2004. (Pubitemid 38833996)
106. Doostdar H, Burke MD, Mayer RT. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicol 144: 31-38, 2000. (Pubitemid 30201617)
107. Etcheverry SB, Ferrer EG, Naso L, Rivadeneira J, Salinas V, Williams PAM. Antioxidant effects of the VO (IV) hesperidin complex and its role in cancer chemoprevention. J Biol Inorg Chem 13: 435-447, 2008.